pharmaceuticals-03-02197
Category: Research
Treatment of Crohn’s Disease with Cannabis- An Observation …
Crohn – tikun olam
Research: Indirect modulation of the endocannabinoid system …
Abstract CONTEXT: Nutmeg [Myristica fragrans Houtt. (Myristicaceae)] has a long-standing reputation of psychoactivity. Anecdotal reports of nutmeg use as a cheap marijuana substitute, coupled to previous studies reporting a cannabimimetic-like action, suggest that nutmeg may interact with the endocannabinoid system. Read More …
Anti-inflammatory and antioxidant effects of a combination o …
Abstract Inflammatory response plays an important role in the activation and progress of many debilitating diseases. Natural products, like cannabidiol, a constituent of Cannabis sativa, and moringin, an isothiocyanate obtained from myrosinase-mediated hydrolysis of the glucosinolate precursor glucomoringin present in Read More …
Attitudes of Israeli Rheumatologists to the Use of Medical C …
Abstract BACKGROUND: While medical cannabis has been used for thousands of years in the treatment of pain and other symptoms, evidence-based use is limited and practitioners face multiple areas of uncertainty regarding the rational use of these compounds. Nonetheless, an Read More …
Marijuana-derived Δ-9-tetrahydrocannabinol suppresses Th1/T …
Abstract ∆9-Tetrahydrocannabinol (THC) is one of the major bioactive cannabinoids derived from the Cannabis sativa plant and is known for its anti-inflammatory properties. Delayed-type hypersensitivity (DTH) is driven by proinflammatory T helper cells including the classic inflammatory Th1 lineage as Read More …
Cannabidiol promotes browning in 3T3-L1 adipocytes.
Abstract Recruitment of the brown-like phenotype in white adipocytes (browning) and activation of existing brown adipocytes are currently being investigated as a means to combat obesity. Thus, a wide variety of dietary agents that contribute to browning of white adipocytes have Read More …
Medical cannabis associated with decreased opiate medication …
Abstract Opioids are commonly used to treat patients with chronic pain (CP), though there is little evidence that they are effective for long term CP treatment. Previous studies reported strong associations between passage of medical cannabis laws and decrease in Read More …
Medical marijuana programs — Why might they matter for pub …
Abstract Objective Although cannabis is an illegal drug, ‘medical marijuana programs’ (MMPs) have proliferated (e.g., in Canada and several US states), allowing for legal cannabis use for therapeutic purposes. While both health risks and potential therapeutic benefits for cannabis use Read More …
Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tole …
Authors: Zhang M, Wang K, Ma M, Tian S, Wei N, Wang G. Abstract BACKGROUND: Morphine is widely used in patients with moderate and severe cancer pain, whereas the development of drug tolerance remains a major problem associated with opioid Read More …